Argus raises Salesforce price target to $300 after FY27 guidance lift
Argus raised its Salesforce price target to $300 from $290 on August 31, 2026, while keeping a Buy rating, making today’s Salesforce news a fresh analyst endorsement of the company’s post earnings AI recovery story. The Argus target move reported through TipRanks was also confirmed in Benzinga’s analyst rating feed, which lists Joseph Bonner of Argus Research raising the target on CRM shares. The call is anchored less in a single headline beat and more in Salesforce’s raised FY27 guidance, improving contract momentum, and deeper Anthropic relationship.
Argus raises Salesforce price target to $300 after FY27 guidance increase
Argus’ $300 target is a modest numerical lift, but the timing makes it more meaningful. The Investing.com report on the Argus call said the firm tied the move to Salesforce raising full year guidance for a second time and to management’s expectation for revenue acceleration in the second half of fiscal 2027.
Argus also raised its fiscal 2027 non GAAP EPS estimate to $16.68 from $14.41, while leaving fiscal 2028 at $15.55. In practice, that makes the call a validation of Salesforce’s near term execution rather than a sweeping change to the longer term model.
Salesforce Q2 FY27 results gave Argus a stronger revenue case
Salesforce’s August 26 results gave analysts fresh numbers to work with, but the key support for Argus is contract and guidance momentum. Salesforce reported current remaining performance obligation of $33.5 billion, up 14% year over year in constant currency, and revenue of $11.3 billion, up 11% year over year. It also raised FY27 revenue guidance to $46.1 billion to $46.4 billion in its second quarter fiscal 2027 results.
The nuance is that Salesforce’s earnings beat was not entirely a clean operating signal. Salesforce said gains on strategic investments added $2.53 to non GAAP diluted EPS in the quarter, so the stronger argument for the stock is the combination of cRPO, subscription growth, and guidance, not just the headline EPS number.
Anthropic Claudeforce deal strengthens Salesforce AI CRM story
Argus’ note also pointed to the Anthropic partnership, which matters because Salesforce has been under pressure to prove that generative AI helps its platform rather than bypasses it. The Claudeforce announcement from Salesforce and Anthropic gives that defense a clearer shape: Salesforce in Claude includes 37 prebuilt sales skills, routes actions through Salesforce business rules, and is available to select pilot customers before an expected open beta in September 2026.
For customers, the practical question is whether that becomes a usable workflow or another premium layer that requires heavy admin work, data cleanup, and governance review. For investors, the near term point is simpler: Salesforce can now argue that Claude is not just a competing interface, but a controlled channel into Salesforce data, workflows, and permissions.
Salesforce stock now needs second half revenue acceleration
The August 31 Salesforce alert from MarketBeat put the implied upside from Argus’ $300 target at 16.91% from the prior close. That upside matters because Salesforce shares had already rebounded sharply after earnings, so the market is no longer pricing the company only as an AI disruption casualty.
The risk is execution. A $300 target assumes that the second half reacceleration shows up in reported revenue and remaining performance obligations, not just in AI product language. Agentforce and Data 360 ARR reached nearly $3.9 billion in Q2, but investors will still separate durable subscription expansion from pilot activity, bundled AI adoption, and strategic investment gains.
The Argus call is a confidence signal with a clear test attached. Salesforce has bought itself more credibility after Q2, but the next movement in CRM stock depends on whether AI demand becomes recurring revenue at a pace that supports the higher target.
Share With Others
Platinum
